Foresite Capital Management Iv, LLC Kura Oncology, Inc. Transaction History
Foresite Capital Management Iv, LLC
- $87.8 Million
- Q1 2025
A detailed history of Foresite Capital Management Iv, LLC transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Foresite Capital Management Iv, LLC holds 1,111,882 shares of KURA stock, worth $6.53 Million. This represents 8.35% of its overall portfolio holdings.
Number of Shares
1,111,882
Previous 1,726,882
35.61%
Holding current value
$6.53 Million
Previous $15 Million
51.21%
% of portfolio
8.35%
Previous 13.82%
Shares
7 transactions
Others Institutions Holding KURA
# of Institutions
190Shares Held
79MCall Options Held
76KPut Options Held
85.8K-
Bvf Inc San Francisco, CA7.75MShares$45.5 Million2.25% of portfolio
-
Suvretta Capital Management, LLC New York, NY7.44MShares$43.7 Million2.15% of portfolio
-
Black Rock Inc. New York, NY6.97MShares$40.9 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY6.57MShares$38.6 Million0.66% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.95MShares$29 Million0.0% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $393M
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...